Zobrazeno 1 - 10
of 415
pro vyhledávání: '"M. Rozencweig"'
Autor:
N. Azarnia, José Baselga, Alexey Manikhas, Vladimir Semiglazov, Clifford A. Hudis, R.H. Goldfarb, S. Forenza, M. Rozencweig, Javier Cortes, J. Matera, Mikhail Byakhov, L Roman, D. Lokanatha, Antonio Llombart
Publikováno v:
Annals of Oncology
Nonpegylated liposomal doxorubicin liposomal doxorubicin, (Myocet™; Sopherion Therapeutics, Inc Canada, and Cephalon, Europe) (NPLD; Myocet(®)) in combination with trastuzumabHerceptin(®) (Hoffmann-La Roche) has shown promising activity and cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45146a7c7884585c5f0c0e0d6173d3c
https://pubmed.ncbi.nlm.nih.gov/24401928
https://pubmed.ncbi.nlm.nih.gov/24401928
Autor:
Alexey Manikhas, S. Forenza, N. Azarnia, M. Rozencweig, J. Matera, Clifford A. Hudis, Vladimir Semiglazov, J. Baselga, L Roman, Ronald H. Goldfarb
Publikováno v:
Cancer Research. 70:P6-14
Background: Myocet™ (M) is a non-pegylated liposomal doxorubicin which exhibits reduced cardiotoxicity as compared to conventional doxorubicin. A phase 1/2 non-randomized multi-site trial combining M, trastuzumab (H) and paclitaxel (T) has resulted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::699d7300720678c5b56fec8547f08e2a
https://doi.org/10.1158/0008-5472.sabcs10-p6-14-02
https://doi.org/10.1158/0008-5472.sabcs10-p6-14-02
Publikováno v:
Harefuah. 128(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5fc827137ed3942c25adcfb170f3953f
https://pubmed.ncbi.nlm.nih.gov/7759013
https://pubmed.ncbi.nlm.nih.gov/7759013
Autor:
N, Onetto, R, Canetta, B, Winograd, R, Catane, M, Dougan, J, Grechko, J, Burroughs, M, Rozencweig
Publikováno v:
Journal of the National Cancer Institute. Monographs. (15)
The safety profile of Taxol administered intravenously as a single agent has been established based on the experience of 655 patients. Of these patients, 253 were treated in nine phase I studies, and 402 were treated in eight disease-oriented phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a970f5ba8bddf9f79387f260a3a33c97
https://pubmed.ncbi.nlm.nih.gov/7912519
https://pubmed.ncbi.nlm.nih.gov/7912519
Autor:
L P, Schacter, C, Anderson, R M, Canetta, S, Kelley, C, Nicaise, N, Onetto, M, Rozencweig, L, Smaldone, B, Winograd
Publikováno v:
Seminars in oncology. 19(6)
The discovery and development of new anticancer drugs is a complex and largely empirical process. New compounds can be discovered by screening, modification of existing compounds, rational drug design, and serendipitous basic research observations. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7fca216f5aea353e8dc1a2c298c909a8
https://pubmed.ncbi.nlm.nih.gov/1462163
https://pubmed.ncbi.nlm.nih.gov/1462163
Publikováno v:
Seminars in oncology. 17(6 Suppl 9)
Hormonal therapy of breast cancer is widely used and effective. Although never curative in advanced disease, significant palliation and durable remissions can be obtained with a wide variety of hormonal manipulations. Historically, surgical ablation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7fc5dbba5ae1f04891986dc5a17009ec
https://pubmed.ncbi.nlm.nih.gov/2148026
https://pubmed.ncbi.nlm.nih.gov/2148026
Publikováno v:
The Journal of Clinical Pharmacology. 18:29-34
The potency of 5 migrogram moxestrol (R 2858). 11beta-methoxy-17alpha-ethinyl-estra-1,3,5-[10]-triene-3,17-diol, administered orally, was compared to that of 25 microgram ethinyl estradiol in a double-blind crossover clinical pharmacology study of si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b5e46badb41ae098fbbb4aabd85c1c
https://doi.org/10.1002/j.1552-4604.1978.tb01557.x
https://doi.org/10.1002/j.1552-4604.1978.tb01557.x
Autor:
E. Longeval, Marc L'Hermite, E. Van Cauter, Abraham Borkowski, Carl Muquardt, M. Rozencweig, Pierre Dor
Publikováno v:
Journal of Endocrinology. 73:235-246
The endocrine response to prolonged dexamethasone treatment was investigated in six postmenopausal women with generalized mammary carcinoma. Plasma cortisol levels decreased rapidly and became undetectable whereas significant concentrations of plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ce1b4adf3918197c58ed58e7a4fe03
https://doi.org/10.1677/joe.0.0730235
https://doi.org/10.1677/joe.0.0730235
Autor:
A. Lieber, H.P. Morris, E. Jacobs, K. Schieweck, M.H. Cohen, E.P. Ho, A.I. Kolosov, U. Joss, G. Weber, L. Bellelli, M.M. Reddy, Roslyn Kushinsky, B.L. Strauss, V.N. Anisimov, A.L. Truant, M. Muggia, M.A. Lea, A. Furst, D.R. Webb, F.H. DeLand, J.L. Gainer, K.H. Schmidt-Ruppin, Sophia Tsang, R.P. Pugh, Maria O. Hornung, C.J. Louis, Maria Luisa Sezzi, M. Rozencweig, D.C. Stolinsky, D. Abraham, J.R. Jones, St.P.L. Leong, L. Sadoff, Y. Maruyama, G.P. Tryfiates, S.S. Legha, A.B. Okey, Maria Ardeleanu, E.T. Krementz, J.V. Hallum, W.J. Durkin, L.N. Bulovskaya, C.M. Ianicello, I. Laszlo, T. Pajak, V.M. Dilman, J.R. Bateman, J.K. Shuler, K.O. Goh, J.M. Weiner, D.D. VonHoff, F. Fodor, Doina Pop D. Popa, M. Kerekes, J.W.T. Dickerson, J. Solomon, T.K. Basu, M. Slavik, L. Schuller, D.A. Wallis
Publikováno v:
Oncology. 33:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714a184773bc13078be9046482a70d4a
https://doi.org/10.1159/000225142
https://doi.org/10.1159/000225142
Publikováno v:
Cancer Chemotherapy and Pharmacology. 1:83-90
The antitumor antibiotics are a heterogeneous group of antineoplastic agents which share a common origin as fermentation products of microbial cultures. This brief review of selected agents will emphasize those agents that play a major role in curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c3951aa9780e8a1e9489aa0ade7f518
https://doi.org/10.1007/bf00254041
https://doi.org/10.1007/bf00254041